In the Margins
Hedge-fund billionaire John Paulson has joined the Valeant Pharmaceuticals International board of directors. Paulson has been one of the largest shareholders in the company for several years, but a series of scandals at Valeant over its accounting practices and drug pricing have battered the company’s stock and caused the value of Paulson’s stake to plunge 81% to $245 million at the end of last year from $1.3 billion in 2015. Read the original story from The Wall Street Journal.
Most Read
Mutual fund independent directors earned more in 2024 than in the year prior, and the pace at which their compensation grew was also higher year-on-year, according ...
The two longest-serving independent directors of ASA Gold and Precious Metals Ltd. have resigned from the board, and all litigation pursued by activist investor Saba Capital ...
Fund Board Views has refreshed and expanded its Editorial Think Tank ahead of its 10-year anniversary this fall. The nine members will continue to work closely with ...
The Securities and Exchange Commission last week dismissed charges against the defendants in the first-ever case related to enforcement of the liquidity risk management rule adopted ...